<p>(A) Constitutive expression of IL-27Rα and gp130 was analyzed by FACS on 4 melanoma cell lines as indicated. (B) Expression of <i>IL-10</i> was analyzed by qPCR in the A375 melanoma cell line cultured for 3 days in the presence or absence of IL-27 or TGF-ß1. (C) Supernatants from the A375 cell line cultured for 3 and 4 days in the presence or absence of IL-27 or TGF-ß1 were tested for IL-10 by ELISA. A representative experiment of 3 is shown in (B) and (C). (D) Distribution of cases that expressed IL-10 or not, among IL-27-negative or -positive cutaneous and metastatic melanomas. (E) Staining for IL-10 in a case of a primary cutaneous melanoma and a case of metastatic melanoma that were positive for IL-27. The bar represents 100 µM.</p
BACKGROUND: To date, serological markers to monitor melanoma progression and response to therapy are...
<p>(A) Human melanoma cell lines (SK-MEL-13, -28, and -37) were stimulated with IL-27 (1, 3, 10 ng/m...
The reactivity spectrum of an anti-CALLA/CD10 monoclonal antibody for cutaneous melanoma was analyse...
<p>(A) Expression of <i>PD-L1</i> (<i>CD274</i>) was analyzed by qPCR in melanoma cell lines culture...
<p>Analysis of IL-27 expression in primary cutaneous and metastatic melanoma from single patients.</...
Interleukin (IL)-27 is a cytokine of the IL-12 family that displays either immunostimulatory or immu...
Interleukin (IL)-27 is a cytokine of the IL-12 family that displays either immunostimulatory or immu...
<p>(A) Human melanoma cell lines (SK-MEL-13, -28, and -37) were stimulated with IL-27 (10 ng/ml) for...
<p>Serial sections from the primary cutaneous melanoma and the corresponding metastasis from two pat...
Background: The immune response in patients with melanoma is an important focus of research due to t...
<p>(A-C) Human melanoma cell lines (SK-MEL-13, -28, and -37) were stimulated with IL-27 (1, 3, 10 ng...
<p>(A) Percentage of IL-27-negative or -positive cases depending on the histological stage of the me...
<p>(A-B) Serial sections of a case of nevus were analyzed for Melan A, a marker of melanocytic cells...
IL-27 has been shown to have both tumor promoting and suppressing functions. IL-27, with its diverse...
This thesis examines the hypothesis that melanoma cells produce immunomodulatory and growth regulato...
BACKGROUND: To date, serological markers to monitor melanoma progression and response to therapy are...
<p>(A) Human melanoma cell lines (SK-MEL-13, -28, and -37) were stimulated with IL-27 (1, 3, 10 ng/m...
The reactivity spectrum of an anti-CALLA/CD10 monoclonal antibody for cutaneous melanoma was analyse...
<p>(A) Expression of <i>PD-L1</i> (<i>CD274</i>) was analyzed by qPCR in melanoma cell lines culture...
<p>Analysis of IL-27 expression in primary cutaneous and metastatic melanoma from single patients.</...
Interleukin (IL)-27 is a cytokine of the IL-12 family that displays either immunostimulatory or immu...
Interleukin (IL)-27 is a cytokine of the IL-12 family that displays either immunostimulatory or immu...
<p>(A) Human melanoma cell lines (SK-MEL-13, -28, and -37) were stimulated with IL-27 (10 ng/ml) for...
<p>Serial sections from the primary cutaneous melanoma and the corresponding metastasis from two pat...
Background: The immune response in patients with melanoma is an important focus of research due to t...
<p>(A-C) Human melanoma cell lines (SK-MEL-13, -28, and -37) were stimulated with IL-27 (1, 3, 10 ng...
<p>(A) Percentage of IL-27-negative or -positive cases depending on the histological stage of the me...
<p>(A-B) Serial sections of a case of nevus were analyzed for Melan A, a marker of melanocytic cells...
IL-27 has been shown to have both tumor promoting and suppressing functions. IL-27, with its diverse...
This thesis examines the hypothesis that melanoma cells produce immunomodulatory and growth regulato...
BACKGROUND: To date, serological markers to monitor melanoma progression and response to therapy are...
<p>(A) Human melanoma cell lines (SK-MEL-13, -28, and -37) were stimulated with IL-27 (1, 3, 10 ng/m...
The reactivity spectrum of an anti-CALLA/CD10 monoclonal antibody for cutaneous melanoma was analyse...